Hans Roger Marcus Martensson

Title: The Innovations of Hans Roger Marcus Martensson

Introduction

Hans Roger Marcus Martensson is a notable inventor based in Malmö, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of delayed release formulations. With a total of 2 patents to his name, Martensson's work is recognized for its potential impact on medication delivery systems.

Latest Patents

Martensson's latest patents focus on delayed release pharmaceutical formulations comprising valproic acid. These formulations include one or more components containing valproic acid (VPA) and/or a pharmaceutically acceptable salt thereof, along with one or more secondary acids. Additionally, these formulations may contain one or more pharmaceutically acceptable excipients. The innovative aspect of his work lies in the various uses of such formulations, which aim to enhance the efficacy and safety of pharmaceutical treatments.

Career Highlights

Martensson is currently associated with Cereno Scientific AB, where he continues to advance his research in pharmaceutical formulations. His expertise in this area has positioned him as a valuable asset to the company and the broader scientific community.

Collaborations

Martensson has collaborated with notable colleagues, including Nils Ove Gustafsson and Sverker Jern. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Hans Roger Marcus Martensson's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving medication delivery systems. His work continues to influence the industry and pave the way for future advancements.